产品
编 号：F742448
分子式：C50H70N14O19S6
分子量：1363.56
分子式：C50H70N14O19S6
分子量：1363.56
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
CAS No: 1092457-78-7
产品详情
生物活性：
MM 419447, a linaclotide metabolite, is a guanylate cyclase-C agonist. MM 419447 has the potential for the research of the irritable bowel syndrome with constipation (IBS-C).
体内研究：
MM 419447 (10 mg/kg; p.o.) treatment shows the Cmax, AUC0-6 and t1/2 values of 27 ng/mL, ≤ 29.7 ng h/mL and 0.33 hours, respectivelyAnimal Model:Female Sprague-Dawley rats
Dosage:10 mg/kg
Administration:P.o. (Pharmacokinetic Analysis)
Result:The Cmax, AUC0-6 and Tmax were 27 ng/mL, ≤ 29.7 ng h/mL and 0.33 hours, respectively.
体外研究：
MM 419447 exhibits high-affinity binding to T84 cells, resulting in a significant, concentration-dependent accumulation of intracellular cyclic guanosine-39,59-monophosphate (cGMP).
MM 419447, a linaclotide metabolite, is a guanylate cyclase-C agonist. MM 419447 has the potential for the research of the irritable bowel syndrome with constipation (IBS-C).
体内研究：
MM 419447 (10 mg/kg; p.o.) treatment shows the Cmax, AUC0-6 and t1/2 values of 27 ng/mL, ≤ 29.7 ng h/mL and 0.33 hours, respectivelyAnimal Model:Female Sprague-Dawley rats
Dosage:10 mg/kg
Administration:P.o. (Pharmacokinetic Analysis)
Result:The Cmax, AUC0-6 and Tmax were 27 ng/mL, ≤ 29.7 ng h/mL and 0.33 hours, respectively.
体外研究：
MM 419447 exhibits high-affinity binding to T84 cells, resulting in a significant, concentration-dependent accumulation of intracellular cyclic guanosine-39,59-monophosphate (cGMP).
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备